We are live on ! Find out more
APTX

Aptinyx Inc. Common Stock

Delisted

APTX was delisted on the 18th of May, 2023.

57 hedge funds and large institutions have $59.5M invested in Aptinyx Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

15% less funds holding

Funds holding: 6757 (-10)

25% less capital invested

Capital invested by funds: $79.3M → $59.5M (-$19.8M)

33% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 24

Holders
57
Holders Change
-10
Holders Change %
-14.93%
% of All Funds
1.24%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
16
Increased
13
Reduced
14
Closed
24
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SO
76
STRS Ohio
Ohio
-$15K -3,800 Closed
PHK
77
Point72 Hong Kong
Hong Kong
-$15K -3,656 Closed
Canada Life
78
Canada Life
Manitoba, Canada
-$10K -2,548 Closed
AIP
79
Ameritas Investment Partners
Nebraska
-$4K -1,097 Closed
Bank of Montreal
80
Bank of Montreal
Ontario, Canada
+$174 +49 +445%

APTX Hedge Fund Activity: Q2 2019 in Review

57 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Aptinyx Inc. Common Stock (APTX) for Q2 2019, worth a combined $59.5M — down 25% from $79.3M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of APTX and 16 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 13 added.

The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $1.68M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $7.27M sold.

  • 57 institutional investors held Aptinyx Inc. Common Stock (APTX) as of Q2 2019, down from 67 in Q1 2019.
  • Funds reported $59.5M of Aptinyx Inc. Common Stock stock for Q2 2019, down 25% quarter-over-quarter.
  • 16 funds opened new Aptinyx Inc. Common Stock positions in Q2 2019 and 24 closed out, a net change of -8 holders.
  • The largest Aptinyx Inc. Common Stock buyer in Q2 2019 was Assenagon Asset Management, an estimated $1.68M added.
  • The largest Aptinyx Inc. Common Stock seller in Q2 2019 was PFM Health Sciences, an estimated $7.27M sold.

Based on aggregated 13F filings for Q2 2019.